CBT
BIO icon

Capital Bank & Trust’s Bio-Rad Laboratories Class A BIO Stock Holding History

Capital Bank & Trust’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-5
Closed -$2K – 331
2020
Q1 		$2K Buy
+5
New +$1.84K ﹤0.01% 630
2019
Q2 		– Sell
-20
Closed -$6K – 678
2019
Q1 		$6K Buy
+20
New +$5.4K ﹤0.01% 573
2018
Q2 		– Sell
-100
Closed -$25K – 689
2018
Q1 		$25K Hold
100
– – ﹤0.01% 448
2017
Q4 		$24K Hold
100
– – ﹤0.01% 480
2017
Q3 		$22K Hold
100
– – ﹤0.01% 437
2017
Q2 		$23K Buy
+100
New +$21.8K ﹤0.01% 404

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $501B AUM 22.01% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return